March 31, 2014 — BioCardia Inc. announced it received CE mark for its Morph AccessPro steerable introducer, designed for easier navigation through the vasculature during delivery of biotherapeutics and medical devices.

March 31, 2014 — Biotronik announced new results from a sub-analysis of the TRUST trial, published in the European Heart Journal. This analysis examined recommended ICD (implantable cardioverter defibrillator) follow-up methods by comparing patient adherence in two groups: those who were given remote follow-ups with Biotronik Home Monitoring and those who had calendar-based, in-person follow-ups. Over the 15-month follow-up period, patient adherence was found to be 25 percent higher in the Home Monitoring group.


March 31, 2014 — Led by members of the American College of Cardiology (ACC), American Heart Association (AHA) and Society for Cardiovascular Angiography and Interventions (SCAI), 14 professional societies from across the world have developed a health policy statement that defines the clinical standards for structured reporting in the cardiac catheterization suite.
Terumo Corp. Arterial Remodeling Technologies Bioresorbable Coronary Stent

Privately held Arterial Remodeling Technologies (ART) signed a structured buyout agreement with Terumo Corp. Under the agreement, ART and Terumo Corp. will collaborate in the development of a drug eluting bioresorbable scaffold or stent, intended for use in the treatment of coronary artery disease. 

eCardio Diagnostics will highlight its expertise for integrating its services with customers' existing electronic medical records (EMR) systems at upcoming conferences.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now